Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$622M |
| 2 |
Alibaba
BABA
|
+$509M |
| 3 |
Goldman Sachs
GS
|
+$500M |
| 4 |
Microsoft
MSFT
|
+$365M |
| 5 |
Halliburton
HAL
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$686M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$629M |
| 3 |
Kroger
KR
|
+$617M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$545M |
| 5 |
Morgan Stanley
MS
|
+$389M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.67% |
| 2 | Technology | 18.06% |
| 3 | Healthcare | 16.18% |
| 4 | Communication Services | 11.92% |
| 5 | Financials | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISBC
401
DELISTED
Investors Bancorp, Inc.
ISBC
| $21.3M | 0.02% |
1,774,136
+4,301
| +0.2% | +$49.9K |
|
|
TMH
402
DELISTED
Team Health Holdings Inc
TMH
| $21.3M | 0.02% |
654,393
-63,153
| -9% | -$2.33M |
|
|
ROIC
403
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $21.2M | 0.02% |
967,480
-115,105
| -11% | -$2.56M |
|
404
Tempest Therapeutics
TPST
$14.5M
| $21.2M | 0.02% |
1,013
-42
| -4% | -$760K |
|
405
Ocular Therapeutix
OCUL
$1.85B
| $20.6M | 0.02% |
3,004,521
+31,915
| +1% | +$195K |
|
|
BEAV
406
DELISTED
B/E Aerospace Inc
BEAV
| $20.5M | 0.02% |
+397,524
| New | +$19.2M |
|
407
United Parks & Resorts
PRKS
$2.17B
| $20.5M | 0.02% |
1,519,976
-2,553,807
| -63% | -$35M |
|
|
CMBT
408
CMB.TECH NV
CMBT
$4.45B
| $20.4M | 0.02% |
2,672,039
-1,287,754
| -33% | -$11.3M |
|
|
BECN
409
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $20.1M | 0.02% |
478,321
-54,038
| -10% | -$2.46M |
|
|
ITCI
410
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $20M | 0.02% |
1,313,516
+33,919
| +3% | +$1.37M |
|
|
CALD
411
DELISTED
Callidus Software, Inc.
CALD
| $19.9M | 0.02% |
1,082,099
+453,005
| +72% | +$8.85M |
|
|
GWPH
412
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $19.8M | 0.02% |
148,958
+71,087
| +91% | +$6.79M |
|
|
BLOX
413
DELISTED
Infoblox Inc
BLOX
| $19.8M | 0.02% |
749,498
-371,945
| -33% | -$7.83M |
|
|
DBVT
414
DBV Technologies
DBVT
$802M
| $19.4M | 0.02% |
53,306
-153
| -0.3% | -$53.1K |
|
|
OKS
415
DELISTED
Oneok Partners LP
OKS
| $19.3M | 0.02% |
484,207
+27,290
| +6% | +$1.09M |
|
|
KA
416
DELISTED
Kineta, Inc. Common Stock
KA
| $19.2M | 0.02% |
8,781
+2,816
| +47% | +$5.23M |
|
|
POT
417
DELISTED
Potash Corp Of Saskatchewan
POT
| $19.1M | 0.02% |
1,168,380
-115,653
| -9% | -$1.91M |
|
418
Plains GP Holdings
PAGP
$5.17B
| $18.9M | 0.02% |
549,670
+421,638
| +329% | +$12.7M |
|
419
CALL
Incyte
INCY
$25.7B
| $18.9M | 0.02% |
200,000
| – | – |
|
420
Toll Brothers
TOL
$14.4B
| $18.9M | 0.02% |
+631,284
| New | +$18.2M |
|
|
CWEN.A
421
DELISTED
Clearway Energy Class A
CWEN.A
| $18.8M | 0.02% |
1,152,219
-230,101
| -17% | -$3.8M |
|
|
INXN
422
DELISTED
Interxion Holding N.V.
INXN
| $18.8M | 0.02% |
518,725
-441,677
| -46% | -$16.5M |
|
423
Littelfuse
LFUS
$9.72B
| $18.8M | 0.02% |
+145,683
| New | +$17.9M |
|
424
Rocket Pharmaceuticals
RCKT
$352M
| $18.7M | 0.02% |
494,038
+6,941
| +1% | +$218K |
|
425
Neurocrine Biosciences
NBIX
$18.2B
| $18.6M | 0.02% |
368,156
-1,656
| -0.4% | -$82.5K |
|
Similar funds
Jennison Associates's Q3 2016 Portfolio in Review
As of Q3 2016, Jennison Associates held 716 positions worth $92.8B, up 1.8% from $91.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Jennison Associates withdrew a net $3.95B in Q3 2016, closing 67 positions and reducing 379 holdings. Its most notable exit was IHS INC CL-A COM STK, an estimated $131M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Jennison Associates opened a new position in FedEx worth $216M.
- Jennison Associates's largest Q3 2016 buy was FedEx: 1,233,863 shares worth $216M.
- Jennison Associates added most to Qualcomm in Q3 2016, an estimated $622M increase.
- Jennison Associates's biggest Q3 2016 reduction was Walt Disney, cutting an estimated $686M.
- Jennison Associates fully exited IHS INC CL-A COM STK in Q3 2016, selling an estimated $131M.
- Jennison Associates's ten largest holdings make up 25% of its $92.8B portfolio in Q3 2016.
- Jennison Associates opened 86 new positions and closed 67 in Q3 2016.
- Jennison Associates's portfolio value rose 1.8% quarter-over-quarter to $92.8B.
Based on Jennison Associates's 13F filing for Q3 2016, filed 1 Nov 2016.